AFX — Carl Zeiss Meditec AG Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Carl Zeiss Meditec AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

	2019 September 30th	R2020 September 30th	2021 September 30th	C2022 September 30th	2023 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	161	123	238	296	292
Depreciation
Non-Cash Items	76.4	58.7	110	52.3	98.4
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-65.7	-64	-46.5	-230	-214
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	220	179	363	188	251
Capital Expenditures	-46.7	-45	-66.1	-82	-114
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-99.1	-26	-9.1	-10.9	2.88
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-146	-70.9	-75.2	-92.9	-111
Financing Cash Flow Items	4.32	-48.8	-224	8.21	-13.7
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	-58.6	-123	-286	-94.2	-135
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	16	-16.4	1.24	0.29	2.87